Sev­en pa­tients di­ag­nosed with blood can­cer af­ter Skysona treat­ment, new da­ta show

Sev­en young boys treat­ed with blue­bird bio’s gene ther­a­py for a rare neu­ro­log­i­cal dis­ease have been di­ag­nosed with blood can­cer months or years af­ter treat­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER